HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Germany's EVP and Vitafy Merge To Combine Online And Offline Expertise

Executive Summary

By joining forces with Vitafy – which offers sports nutrition, supplement and food products through its direct-to-consumer platforms – EVP hopes the enlarged group will become a leading player in the European consumer healthcare market. 

You may also be interested in...

People On The Move: Appointments At EVP, Venture Life And Perrigo

The latest consumer health industry appointments: Germany's Euro Vital Pharma names Kudera as managing director; the UK's Venture Life promotes Wells to CFO; and Perrigo nominates Ashford as its next chairman.

Germany's EVP Enters Spain's Supplements Market With Korott

German private-label specialist EVP Group is poised to enter the Spanish market with the acquisition of local supplements and cosmetics player Korott.

German OTC Private Label Specialist EVP Acquires UK’s Principle Healthcare

Leading German OTC private label manufacturer Euro Vital Pharma has bolstered its offering in the dietary supplements segment by snapping up UK-based Principle Healthcare





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts